收藏切换
“Weibing” in traditional Chinese medicine—biological basis and mathematical representation of disease-susceptible state
收藏切换
PDF
Wanyang Suna, Rong Wanga, Shuhua Ouyanga, Wanli Lianga, b, Junwei Duand, Wenyong Gongc, Lianting Hue, f, Xiujuan Chene, Yifang Lia, Hiroshi Kuriharaa, *, Xinsheng Yaoa, *, Hao Gaoa, *, Rongrong Hea, b, *
Acta Pharmaceutica Sinica B | 2025, 15(5) : 2363 - 2371
Less
收藏切换
Acta Pharmaceutica Sinica B | 2025, 15(5): 2363-2371
REVIEW
“Weibing” in traditional Chinese medicine—biological basis and mathematical representation of disease-susceptible state
Full
Wanyang Suna, Rong Wanga, Shuhua Ouyanga, Wanli Lianga, b, Junwei Duand, Wenyong Gongc, Lianting Hue, f, Xiujuan Chene, Yifang Lia, Hiroshi Kuriharaa, *, Xinsheng Yaoa, *, Hao Gaoa, *, Rongrong Hea, b, *
Affiliations
  • aInstitute of Traditional Chinese Medicine and Natural Products, College of Pharmacy/Guangdong Engineering Research Center of Traditional Chinese Medicine & Disease Susceptibility/Guangdong Engineering Research Center of Traditional Chinese Medicine & Health Products/International Cooperative Laboratory of TCM Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE)/Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research/State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou 510632, China
  • bState Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau 999078, China
  • cFaculty of Data Science, City University of Macau, Macau 999078, China
  • dCollege of Information Science and Technology, Jinan University, Guangzhou 510632, China
  • eMedical Big Data Center, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510632, China
  • fThe Data Center, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430016, China
About Author:

E-mail addresses: (Rongrong He),

(Hao Gao),

(Xinsheng Yao),

(Hiroshi Kurihara).

These authors made equal contributions to this work.

Author contributions

Rong-Rong He, Hao Gao, Hiroshi Kurihara, and Xin-Sheng Yao conceived the project. Wan-Yang Sun, Rong Wang, and Rong-Rong He drafted the original manuscript. Shu-Hua Ouyang, Junwei Duan, Wan-Li Liang, Wen-Yong Gong, Lian-Ting Hu, Xiu-Juan Chen, and Yi-Fang Li collected and analyzed data. Rong-Rong He and Hao Gao revised the manuscript. All the authors read and approved the final manuscript.

doi: 10.1016/j.apsb.2025.03.009
Outline
收藏切换

“Weibing” is a fundamental concept in traditional Chinese medicine (TCM), representing a transitional state characterized by diminished self-regulatory abilities without overt physiological or social dysfunction. This perspective delves into the biological foundations and quantifiable markers of Weibing, aiming to establish a research framework for early disease intervention. Here, we propose the “Health Quadrant Classification” system, which divides the state of human body into health, sub-health, disease-susceptible state, and disease. We suggest the disease-susceptible stage emerges as a pivotal point for TCM interventions. To understand the intrinsic dynamics of this state, we propose laboratory and clinical studies utilizing time-series experiments and stress-induced disease susceptibility models. At the molecular level, bio-omics technologies and bioinformatics approaches are highlighted for uncovering intricate changes during disease progression. Furthermore, we discuss the application of mathematical models and artificial intelligence in developing early warning systems to anticipate and avert the transition from health to disease. This approach resonates with TCM’s preventive philosophy, emphasizing proactive health maintenance and disease prevention. Ultimately, our perspective underscores the significance of integrating modern scientific methodologies with TCM principles to propel Weibing research and early intervention strategies forward.

Weibing  /  Disease-susceptible state  /  Traditional Chinese medicine  /  Preventive medicine  /  Mathematical modeling
Wanyang Sun, Rong Wang, Shuhua Ouyang, Wanli Liang, Junwei Duan, Wenyong Gong, Lianting Hu, Xiujuan Chen, Yifang Li, Hiroshi Kurihara, Xinsheng Yao, Hao Gao, Rongrong He. “Weibing” in traditional Chinese medicine—biological basis and mathematical representation of disease-susceptible state[J]. Acta Pharmaceutica Sinica B, 2025 , 15 (5) : 2363 -2371 . DOI: 10.1016/j.apsb.2025.03.009
“Weibing” (Chinese expression in Supporting Information), a pivotal concept in traditional Chinese medicine (TCM), refers to a health status characterized by a subtle decline in an individual’s innate abilities for self-organization, adaptation, and repair, without significantly compromising physiological or social functions. The traditional Weibing theory revolves around four core principles: forestalling disease onset, arresting its progression, mitigating exacerbation, and averting recurrence. These principles are deeply entrenched in preventive medicine, advocating proactive health maintenance strategies to delay or avert the onset of illness. Specifically, preventive actions should be initiated during healthy period to safeguard against sickness. Upon disease diagnosis, efforts must concentrate on halting its progression and preventing deterioration. In cases where a disease has advanced, the focus shifts to containing further decline. Post-treatment, preventive steps are vital to prevent recurrence or the emergence of secondary conditions. This approach underscores TCM’s “prevention first” philosophy, where preemptive treatment aligns with broader preventive medicine principles, advancing the objectives of disease prevention and management. Despite its centuries-old theoretical foundation, the biological mechanisms and quantifiable markers of Weibing remain elusive in TCM. Thus, establishing a robust research framework to explore the biological underpinnings of Weibing, develop mathematical models to identify critical states, and implement early warning systems is imperative.
TCM distinguishes itself from modern medical paradigms by its emphasis on the concept of “syndrome”, a nuanced integration of symptoms and signs indicative of specific bodily imbalances or disorders1. Examples include heat syndrome and cold syndrome, each embodying distinct physiological patterns2. A notable example is the “Shanghuo” syndrome3, a subtype of heat syndrome, triggered by multifaceted factors including psychological stress, insomnia, dietary indiscretions, and excessive smoking4-6. The manifestation of “Shanghuo” spans a diverse array of symptoms, varying from generalized expressions like redness, pain, and fever to more localized conditions such as acne outbreaks and nosebleeds. Notably, this syndrome does not correspond directly to a single, definitive disease entity but rather serves as an early indicator of potential health challenges that may emerges7. As a result, the absence of suitable diagnostic models tailored specifically for “Shanghuo” poses challenges in assessing the efficacy of TCM interventions aimed at addressing this condition. Consequently, research and development in this area are crucial to enhance understanding and improve treatment outcomes for individuals experiencing TCM syndromes.
To address the complexity of evaluating TCM treatments aimed at mitigating “Shanghuo” and similar critical states, we propose a refined classification system for health-disease states, grounded in TCM principles. This framework encapsulates four stages: health, sub-health, disease susceptible state, and disease (Fig. 1). Health and a special subcategory of sub-health, devoid of overt pathological markers, comprise the general health stage, necessitating no medication. Conversely, the subsequent stages—specific sub-health and disease-susceptible state—though not diagnostic of specific diseases, represent a generalized sub-health category marked by subtle physiological changes. Crucially, the disease-susceptible state, represents a critical threshold where the body teeters on the brink of full-blown illness. This refined pathological state surpasses the ambiguities of generalized sub-health, highlighting its strategic importance as a pivot for early intervention. In this delicate balance, the body exhibits heightened sensitivity to external stressors, portending a swift descent into disease if left unchecked. As such, disease-susceptible state represents a vital nexus in the TCM paradigm of “preventive treatment of disease,” ideally suited for TCM’s adaptive regulatory strategies.
Overall, Fig. 1 provides a visual representation of the continuum of health states, emphasizing the pivotal role of the disease-susceptible stage in preventive medicine and highlighting the opportunities for early intervention, particularly within the framework of TCM. The timely application of TCM interventions during this critical phase can significantly influence the trajectory of impending illness, averting the onset of full-blown disease and restoring balance to the body. Conversely, the absence of appropriate measures during this window may precipitate a rapid deterioration into disease, exacerbating treatment challenges. Thus, recognizing and addressing disease-susceptible state, as embodied in TCM’s nuanced classification system, holds the key to optimizing health outcomes and preventing the onset of avoidable illnesses.
The intricate dynamics of disease progression underscore the imperative for time-series experiments in elucidating and modeling these complex processes8,9. In the laboratory setting, these experiments on cellular and animal models offer a unique window into the temporal evolution of diseases, allowing researchers to discern patterns and trends over time. While offering unparalleled insights, such studies confront challenges, including sample grouping limitations and the demands of extended follow-up, especially for chronic diseases characterized by lengthy onset periods. To overcome these obstacles, we previously employ various stress factors and classic disease inducers to expedite the transition of models into critical disease states, particularly among those in suboptimal health. By employing psychological stress and classic disease-inducing factors, researchers have successfully constructed disease-susceptibility models for major diseases, including viral infections10-12, neurodegenerative diseases13-17, tumors18-21, metabolic diseases22,23, immune diseases24,25, and cardiovascular diseases26,27. These models allow the evaluation of the efficacy of both TCM formula28-32 and active compounds33-38. The disease-susceptibility model makes it easier for experimental animals to be in a disease-susceptible state or critical transformation state, at which point TCM intervention can effectively delay or even reverse disease progression.
Translating these laboratory findings into clinical practice, however, necessitates the acquisition of high-quality clinical data that meticulously documents disease progression. Longitudinal studies, particularly cohort, interventional longitudinal, and longitudinal case-series studies, offer robust methodologies for monitoring disease evolution over time. Cohort studies, for instance, prospectively follow individuals to uncover disease development patterns, as exemplified by research on chronic kidney disease progression39. Interventional longitudinal studies, by exposing healthy subjects to pathogens and tracking symptomology and gene expression over time, yield invaluable insights into the temporal profiles of host responses40. Meanwhile, longitudinal case-series studies meticulously track individual disease trajectories, pinpointing critical intervention junctures despite their data-intensive requirements. Recognizing the constraints associated with traditional longitudinal studies, computational methods leveraging cross-sectional data have emerged as valuable complements41. These techniques reconstruct time-series models from cross-sectional snapshots, enabling the identification of distinct disease states and their temporal progression, even in the absence of direct time-series data. This strategy has demonstrated remarkable success in modeling glaucoma, breast cancer, Parkinson’s disease, and myelodysplastic syndromes42-45, revolutionizing our comprehension of disease mechanisms and intervention strategies.
In conclusion, a multifaceted approach that integrates laboratory experimentation, clinical studies, and computational modeling holds immense promise for advancing our understanding of disease-susceptible states and facilitating the development of targeted interventions that can significantly impact public health outcomes.
The physiological characteristics of a patient can be primarily assessed through two distinct lenses: macroscopic approaches, encompassing clinical signs and imaging, and microscopic approaches, focusing on molecular data. For macroscopic analysis, both modern medicine and TCM offer diagnostic methodologies. Modern medicine primarily utilizes advanced clinical examination and imaging techniques to discern health and disease states46. In contrast, TCM relies on the “Four Diagnostic Methods” - observation, auscultation, interrogation, and palpation - to analyze the body’s response, dynamics, and changes throughout the disease process47. This leads to the concept of “syndrome,” which captures a specific stage in disease progression and the individual’s internal and external environment48,49, manifested through symptoms like tongue and pulse analysis, along with observations of shape, color, and vitality50,51. Notably, the “syndrome” concept has the potential to indicate a disease-susceptible state to a certain degree52. For instance, in the stage of transitioning from hepatitis B carrier to illness, TCM can diagnose imbalances such as Yin-Yang disharmony and Qi-blood disturbance, along with specific syndromes like liver-Qi stagnation, liver fire, Qi stagnation with blood stasis, etc.53
At the microscopic level, disease progression is characterized by continuous changes and dynamic interactions among biomolecules, including genes, proteins, and metabolites54,55. To attain a comprehensive understanding of the dynamic molecular changes occurring within the body during disease progression, bio-omics technology, combined with bioinformatics methods, offers an inclusive perspective by examining the microscopic aspects of the body and analyzing vast quantities of molecular data derived from living organisms56,57. This approach encompasses various fields, such as genomics, transcriptomics, proteomics, metabolomics, and epigenomics. Our recent research has indicated that the body can develop into a disease-susceptible state under stress conditions such as emotions, diet, and environment7,11,58,59. This state is marked by elevated levels of free radicals which can disrupt the cell’s redox balance, leading to an overactive intracellular oxidation reaction (Fig. 2A)60. This, in turn, causes severe lipid peroxidation within cells, significantly modifying proteins and genes through oxidized lipids. Once the oxidation level surpasses a critical threshold, it can rapidly transition into a disease state61. In the disease state, the intracellular oxidation reaction is no longer elevated, but cells have undergone oxidative modification, resulting in a relatively stable but challenging-to-treat state. Thus, intracellular lipid peroxidation products and oxidative modification of genes and proteins may serve as crucial characteristics of disease-susceptible state and merit further investigation (Fig. 2B).
The early warning and prediction of disease-susceptible states are crucial for the implementation of preventive strategies in medicine. Traditional clinical diagnostics, which primarily rely on imaging, biochemical analysis, and pathology, often face significant challenges in distinguishing the critical states from normal conditions. The rapid advancements in artificial intelligence (AI) especially on machine learning (ML) present promising tools to address these challenges. These methods do not rely on explicitly programmed instructions but instead leverage data-driven algorithms to identify patterns and make predictive decisions. Predictive models analyze both longitudinal data (such as sequential clinical assessments, medical imaging, and laboratory diagnostics) and static information (such as the patient’s general characteristics, including age, ethnicity, and genetic markers) to assess current health status and forecast future health outcomes62. Within the realm of AI, various new predictive models can be proposed, via generative intelligence or decision intelligence methods. Traditional ML algorithms, such as decision trees and support vector machines, often require the identification and directly selection of relevant features from data, making them suitable for small sample sizes. In contrast, DL, such as convolutional neural networks (CNN), recurrent neural networks (RNN), and transform, employs multi-layer neural networks to automatically extract features without manual intervention, excelling in handling large-scale and high-dimensional datasets63-65. While traditional machine learning models excel at handling static data, they have limitations in capturing temporal dependencies and dynamic changes within data, a shortcoming effectively addressed by the temporal analysis capabilities of models such as long short-term memory (LSTM). Actually, deep learning-based models have shown potential in addressing these challenges by accurately forecasting disease progressions such as cardiac arrest, respiratory failure, cancer, and depression66-68. The application of deep learning uncovered effective features for predicting patient survival, providing new perspectives for biomarker discovery and enhancing clinical decision-making frameworks69. Additionally, biomarkers and disease can also be effectively recognized using the latest techniques such as GAN, LLM, and CGMformer models70-72. Building on advancements in predictive models and algorithms, we propose a system that integrates temporal and neural networks to predict and diagnose health states. This model employs dynamic space fusion networks and LSTM for multi-level feature mapping, constructing a robust framework for early detection and intervention. By integrating macroscopic and microscopic data from multiple time windows, the model enhances the prediction accuracy of health, disease susceptibility, and disease states (Fig. 3). It serves as a powerful tool in the development of TCM and herbal intervention strategies, providing a robust framework for early detection and timely treatment.
The construction of diagnostic models critically depends on extensive continuous clinical data and often suffers from limited interpretability. This has driven researchers to explore high-dimensional omics data to identify biomarkers capable of characterizing disease-susceptible states. A promising approach in this filed is the identification of the “critical slowing down” (CSD) phenomenon observed during disease progression73. CSD is a phenomenon observed in complex systems across various disciplines, such as physics, biology, and economics, indicating that a system is approaching a tipping point. It is characterized by a decreased recovery rate from perturbations, which can be detected or inferred from increased lag-1 autocorrelation and variance74 (Fig. 4). This discovery has sparked the development of mathematical models designed to capture the universal features of disease-susceptible states. Dynamic network biomarkers (DNB) have emerged as a model-free approach for the early warning of the critical state of disease75-78. By utilizing the principles of nonlinear dynamics and bifurcation theory, DNBs identify functional modules within complex biological networks that undergo dynamic changes over time, rather than relying on a static set of biomolecules. The effectiveness of DNB has been demonstrated in various diseases such as influenza outbreaks, tumor progression, and diabetes79-86. Another notable approach in this field is the UNIQ system, which represents a pioneering method for studying critical disease biomarkers. Rooted in the holistic principles of TCM, the UNIQ system87 integrates the concept of “taking the image and comparing the category” at a microscopic level. This system utilizes a “macro-micro modular correlation” approach, linking the human phenotype network (including clinical manifestations of TCM syndromes) with the biomolecular network (genes, proteins), and drug networks. By objectively and quantitatively describing these relationships, the UNIQ system facilitates a comprehensive decoding of the interactions between diseases, drugs, genes, and proteins. The system has been particularly effective in predicting early biomarkers for diseases like gastric cancer, facilitating earlier interventions and highlighting the potential of TCM in modern medicine88. Moreover, researchers have developed individual-specific methods such as the sample-perturbed network entropy method77, utilizing high-dimensional omics data rich in physiological and pathological features of individual samples, which opens new avenues for personalized and precise prediction. Similarly, gene regulatory network is valuable for predicting critical states by modeling gene interactions, where gene expression is regulated by upstream genes and affects downstream targets. The expression values, defined as gene vectors, can characterize the state of a sample, thereby predicting the transition state89,90. However, translating these biomarker discoveries into clinical practice remains challenging, primarily due to the complexities of omics technologies and the extensive foundational research required. Despite considerable progress in predictive modeling and early detection of diseases, the development of effective models capable of accurately identifying disease progression remains an ongoing challenge. Addressing issues such as small sample sizes, high-dimensional data, and complex data environments will be crucial in advancing this field.
The disease-susceptible state is characterized by its dynamic, multi-dimensional, complex, systemic, and deeply influenced by individual variability. This complexity raises a series of scientific questions that need to be addressed in the modern research of Weibing theory and its clinical practice. These include: 1) The identification of the biomedical basis of Weibing and the key effector molecules driving the development of disease; 2) The establishment of an objective indicator that can quantitatively characterize the state of disease susceptibility; 3) The formation of early warning, prediction methods, and intervention approaches for the disease-susceptible state. To tackle these pressing questions, interdisciplinary collaboration is paramount, informed by the ancient wisdom of traditional Chinese medicine’s “prevention of disease” philosophy. This necessitates the seamless integration of medicine, biology, mathematics, artificial intelligence, and other disciplines, fostering a holistic understanding and innovative solutions. We are confident that with unwavering dedication and continuous endeavors, we can fully exploit the profound implications of the “prevention is better than cure” mindset and usher in a novel paradigm of scientific research centered on “disease prevention” within the framework of TCM.
1.
Jiang M, Lu C, Zhang C, Yang J, Tan Y, Lu A, et al. Syndrome differentiation in modern research of traditional Chinese medicine. J Ethnopharmacol 2012;140:634—42.
2.
Chen P, Wang BY, Zhang P, Li S. Cold and hot syndromes in traditional Chinese medicine: insights from the perspective of immunometabolic homeostasis. World J Tradit Chin Med 2024;10:434—42.
3.
Rongrong H, Hiroshi K. Shanghuo syndrome in traditional Chinese medicine. World Sci Technol 2008;10:37—41.
4.
Tan J, Zhang H, Zhang L, Xu H. Ginseng and “Shanghuo” (fireness): a comprehensive review from the viewpoints of TCM theory and modern science. Food Funct 2023;14:3437—53.
5.
Din Z, Cao H, Zhang Y, Zheng X, Song W. Targeting gut microbiota to explore the Shanghuo effect of Qi-invigorating herbs. Pharmacol Res Mod Chin Med 2024;11:100388.
6.
Hao R, Jiao J, Liu X, Zuo J, Jin H, Wu Y, et al. The effects of big five personality traits on sub-health in a Chinese young adults: a moderated mediation model. J Affective Disord 2024;358:335—41.
7.
Pan MH, Zhu SR, Duan WJ, Ma XH, Luo X, Liu B, et al. “Shanghuo” increases disease susceptibility: modern significance of an old TCM theory. J Ethnopharmacol 2020;250:112491.
8.
Bar-Joseph Z, Gitter A, Simon I. Studying and modelling dynamic biological processes using time-series gene expression data. Nat Rev Genet 2012;13:552—64.
9.
Frishberg A, Milman N, Alpert A, Spitzer H, Asani B, Schiefelbein JB, et al. Reconstructing disease dynamics for mechanistic insights and clinical benefit. Nat Commun 2023;14:6840.
10.
Li W, Luo Z, Yan CY, Wang XH, He ZJ, Ouyang SH, et al. Autophagic degradation of PML promotes susceptibility to HSV-1 by stress-induced corticosterone. Theranostics 2020;10:9032—49.
11.
Luo Z, Liu LF, Jiang YN, Tang LP, Li W, Ouyang SH, et al. Novel insights into stress-induced susceptibility to influenza: corticosterone impacts interferon-β responses by Mfn2-mediated ubiquitin degradation of MAVS. Signal Transduct Target Ther 2020;5:202.
12.
Poller WC, Downey J, Mooslechner AA, Khan N, Li L, Chan CT, et al. Brain motor and fear circuits regulate leukocytes during acute stress. Nature 2022;607:578—84.
13.
Sun WY, Tyurin VA, Mikulska-Ruminska K, Shrivastava IH, Anthonymuthu TS, Zhai YJ, et al. Phospholipase iPLA2β averts ferroptosis by eliminating a redox lipid death signal. Nat Chem Biol 2021;17:465—76.
14.
Sun J, Lin XM, Lu DH, Wang M, Li K, Li SR, et al. Midbrain dopamine oxidation links ubiquitination of glutathione peroxidase 4 to ferroptosis of dopaminergic neurons. J Clin Investig 2023;133:e173110.
15.
Lin XM, Pan MH, Sun J, Wang M, Huang ZH, Wang G, et al. Membrane phospholipid peroxidation promotes loss of dopaminergic neurons in psychological stress-induced Parkinson’s disease susceptibility. Aging Cell 2023;22:e13970.
16.
Tu LF, Zhang TZ, Zhou YF, Zhou QQ, Gong HB, Liang L, et al. GPX4 deficiency-dependent phospholipid peroxidation drives motor deficits of ALS. J Adv Res 2023;43:205—18.
17.
Xia F, Fascianelli V, Vishwakarma N, Ghinger FG, Kwon A, Gergues MM, et al. Understanding the neural code of stress to control anhedonia. Nature 2025;637:654—62.
18.
Wu Y, Luo X, Zhou Q, Gong H, Gao H, Liu T, et al. The disbalance of LRP1 and SIRPalpha by psychological stress dampens the clearance of tumor cells by macrophages. Acta Pharm Sin B 2022;12:197—209.
19.
Luo X, Gong HB, Li ZC, Li DD, Li ZX, Sun J, et al. Phospholipid peroxidation in macrophage confers tumor resistance by suppressing phagocytic capability towards ferroptotic cells. Cell Death Differ 2024;31:1184—201.
20.
Li Z, Xu ZM, Chen WP, Du XJ, Ou CX, Luo ZK, et al. Tumor-repopulating cells evade ferroptosis via PCK2-dependent phospholipid remodeling. Nat Chem Biol 2024;20:1341—52.
21.
He XY, Gao Y, Ng D, Michalopoulou E, George S, Adrover JM, et al. Chronic stress increases metastasis via neutrophil-mediated changes to the microenvironment. Cancer Cell 2024;42:474—86.e12.
22.
Wang M, Liu CY, Wang T, Yu HM, Ouyang SH, Wu YP, et al. (+)-Clausenamide protects against drug-induced liver injury by inhibiting hepatocyte ferroptosis. Cell Death Dis 2020;11:781.
23.
Wang GE, Li YF, Zhai YJ, Gong L, Tian JY, Hong M, et al. Theacrine protects against nonalcoholic fatty liver disease by regulating acylcarnitine metabolism. Metabolism 2018;85:227—39.
24.
Chang H, Perkins MH, Novaes LS, Qian F, Zhang T, Neckel PH, et al. Stress-sensitive neural circuits change the gut microbiome via duodenal glands. Cell 2024;187:5393—412.e30.
25.
Chan KL, Poller WC, Swirski FK, Russo SJ. Central regulation of stress-evoked peripheral immune responses. Nat Rev Neurosci 2023;24:591—604.
26.
Ma XH, Liu JH, Liu CY, Sun WY, Duan WJ, Wang G, et al. ALOX15-launched PUFA-phospholipids peroxidation increases the susceptibility of ferroptosis in ischemia-induced myocardial damage. Signal Transduct Target Ther 2022;7:288.
27.
Yan CY, Ye Y, Mu HL, Wu T, Huang WS, Wu YP, et al. Prenatal hormone stress triggers embryonic cardiac hypertrophy outcome by ubiquitin-dependent degradation of mitochondrial mitofusin 2. iScience 2024;27:108690.
28.
Zhou QQ, Wu YP, Liu P, Deng WZ, Lu YH, Gong HB, et al. Regulation of hepatocyte phospholipid peroxidation signaling by a Chinese patent medicine against psychological stress-induced liver injury. Phytomedicine 2024;129:155613.
29.
Luo X, Li DD, Li ZC, Li ZX, Zou DH, Huang F, et al. Mitigating phospholipid peroxidation of macrophages in stress-induced tumor microenvironment by natural ALOX15/PEBP1 complex inhibitors. Phytomedicine 2024;128:155475.
30.
Ma X, Wang Q, Liu C, Liu J, Luo G, He L, et al. Regulation of phospholipid peroxidation signaling by a traditional Chinese medicine formula for coronary heart disease. Phytomedicine 2023;114:154749.
31.
Jiang YN, Guo YZ, Lu DH, Pan MH, Liu HZ, Jiao GL, et al. Tianma Gouteng granules decreases the susceptibility of Parkinson’s disease by inhibiting ALOX15-mediated lipid peroxidation. J Ethnopharmacol 2020;256:112824.
32.
Chen H, Jie C, Tang LP, Meng H, Li XB, Li YB, et al. New insights into the effects and mechanism of a classic traditional Chinese medicinal formula on influenza prevention. Phytomedicine 2017;27:52—62.
33.
Li K, Wang M, Huang ZH, Wang M, Sun WY, Kurihara H, et al. ALOX5 inhibition protects against dopaminergic neurons undergoing ferroptosis. Pharmacol Res 2023;193:106779.
34.
Weng JY, Chen XX, Wang XH, Ye HE, Wu YP, Sun WY, et al. Reducing lipid peroxidation attenuates stress-induced susceptibility to herpes simplex virus type 1. Acta Pharmacol Sin 2023;44:1856—66.
35.
Ouyang SH, Zhai YJ, Wu YP, Xie G, Wang GE, Mao ZF, et al. Theacrine, a potent antidepressant purine alkaloid from a special Chinese tea, promotes adult hippocampal neurogenesis in stressed mice. J Agric Food Chem 2021;69:7016—27.
36.
Luo Z, Kuang XP, Zhou QQ, Yan CY, Li W, Gong HB, et al. Inhibitory effects of baicalein against herpes simplex virus type 1. Acta Pharm Sin B 2020;10:2323—38.
37.
Duan WJ, Liang L, Pan MH, Lu DH, Wang TM, Li SB, et al. Theacrine, a purine alkaloid from kucha, protects against Parkinson’s disease through SIRT3 activation. Phytomedicine 2020;77:153281.
38.
Luo Z, Liu LF, Wang XH, Li W, Jie C, Chen H, et al. Epigoitrin, an alkaloid from Isatis indigotica, reduces H1N1 infection in stress-induced susceptible model in vivo and in vitro. Front Pharmacol 2019;10:78.
39.
Anderson AH, Xie D, Wang X, Baudier RL, Orlandi P, Appel LJ, et al. Novel risk factors for progression of diabetic and nondiabetic CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis 2021;77:56—73.e1.
40.
Gao R, Yan J, Li P, Chen L. Detecting the critical states during disease development based on temporal network flow entropy. Brief Bioinform 2022;23:bbac164.
41.
South E, Rodgers M. Data visualisation in scoping reviews and evidence maps on health topics: a cross-sectional analysis. Syst Rev 2023;12:142.
42.
Huang X, Kong X, Shen Z, Ouyang J, Li Y, Jin K, et al. GRAPE: a multi-modal dataset of longitudinal follow-up visual field and fundus images for glaucoma management. Sci Data 2023;10:520.
43.
Kim S, Yeo Y, Shin J, Shin DW, Cho B, Song YM. Factors associated with long-term dietary supplement use among Korean breast cancer survivors: a cross-sectional study. Nutrients 2023;15:4087.
44.
Wang X, Yang X, He W, Song X, Zhang G, Niu P, et al. The association of serum neurofilament light chains with early symptoms related to Parkinson’s disease: a cross-sectional study. J Affect Disord 2023;343:144—52.
45.
Abraham L, Paul M, D’souza CO, Sophy MP. Clinical, hematological, and cytogenetic profile of Myelodysplastic Syndromes in adults: a three-year cross-sectional study. Oman Med J 2023;38:e478.
46.
Eskofier BM, Klucken J. Predictive models for health deterioration: understanding disease pathways for personalized medicine. Annu Rev Biomed Eng 2023;25:131—56.
47.
Wang Y, Shi X, Li L, Efferth T, Shang D. The impact of artificial intelligence on traditional Chinese medicine. Am J Chin Med 2021;49:1297—314.
48.
Wenjian W. Theory of “analogous patterns in the same disease” and disease identification in TCM: development of TCM through a scientific outlook. World Sci Technol 2011;13:226—31.
49.
Wang XN, Zhou V, Liu Q, Gao Y, Zhou XH. Evaluation of the accuracy of diagnostic scales for a syndrome in Chinese medicine in the absence of a gold standard. Chin Med 2016;11:35.
50.
Yuan L, Yang L, Zhang S, Xu Z, Qin J, Shi Y, et al. Development of a tongue image-based machine learning tool for the diagnosis of gastric cancer: a prospective multicentre clinical cohort study. EClinicalMedicine 2023;57:101834.
51.
Thomsen KK, Kouz K, Saugel B. Pulse wave analysis: basic concepts and clinical application in intensive care medicine. Curr Opin Crit Care 2023;29:215—22.
52.
Liu R, Li M, Liu ZP, Wu J, Chen L, Aihara K. Identifying critical transitions and their leading biomolecular networks in complex diseases. Sci Rep 2012;2:813.
53.
Lu Y, Fang Z, Zeng T, Li M, Chen Q, Zhang H, et al. Chronic hepatitis B: dynamic change in traditional Chinese medicine syndrome by dynamic network biomarkers. Chin Med 2019;14:52.
54.
Stoney R, Robertson DL, Nenadic G, Schwartz JM. Mapping biological process relationships and disease perturbations within a pathway network. NPJ Syst Biol Appl 2018;4:22.
55.
Qiu S, Cai Y, Yao H, Lin C, Xie Y, Tang S, et al. Small molecule metabolites: discovery of biomarkers and therapeutic targets. Signal Transduct Target Ther 2023;8:132.
56.
Chen R, Mias GI, Li-Pook-Than J, Jiang L, Lam HY, Chen R, et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell 2012;148:1293—307.
57.
Hasin Y, Seldin M, Lusis A. Multi-omics approaches to disease. Genome Biol 2017;18:83.
58.
Yan C, Luo Z, Li W, Li X, Dallmann R, Kurihara H, et al. Disturbed Yin-Yang balance: stress increases the susceptibility to primary and recurrent infections of herpes simplex virus type 1. Acta Pharm Sin B 2020;10:383—98.
59.
Wu Y, Luo X, Zhou Q, Gong H, Gao H, Liu T, et al. The disbalance of LRP1 and SIRPα by psychological stress dampens the clearance of tumor cells by macrophages. Acta Pharm Sin B 2022;12:197—209.
60.
Sies H, Mailloux RJ, Jakob U. Fundamentals of redox regulation in biology. Nat Rev Mol Cell Biol 2024;25:701—19.
61.
Forman HJ, Zhang H. Targeting oxidative stress in disease: promise and limitations of antioxidant therapy. Nat Rev Drug Discov 2021;20:689—709.
62.
van Smeden M, Reitsma JB, Riley RD, Collins GS, Moons KG. Clinical prediction models: diagnosis versus prognosis. J Clin Epidemiol 2021;132:142—5.
63.
Stahlschmidt SR, Ulfenborg B, Synnergren J. Multimodal deep learning for biomedical data fusion: a review. Brief Bioinform 2022;23:bbab569.
64.
Kumar N, Srivastava R. Deep learning in structural bioinformatics: current applications and future perspectives. Brief Bioinform 2024;25:bbae042.
65.
Wang H, Fu T, Du Y, Gao W, Huang K, Liu Z, et al. Scientific discovery in the age of artificial intelligence. Nature 2023;620:47—60.
66.
Kim J, Chae M, Chang HJ, Kim YA, Park E. Predicting cardiac arrest and respiratory failure using feasible artificial intelligence with simple trajectories of patient data. J Clin Med 2019;8:1336.
67.
Lee C, Rashbass J, van der Schaar M. Outcome-oriented deep temporal phenotyping of disease progression. IEEE Trans Biomed Eng 2021;68:2423—34.
68.
Su D, Zhang X, He K, Chen Y. Use of machine learning approach to predict depression in the elderly in China: a longitudinal study. J Affect Disord 2021;282:289—98.
69.
Courtiol P, Maussion C, Moarii M, Pronier E, Pilcer S, Sefta M, et al. Deep learning-based classification of mesothelioma improves prediction of patient outcome. Nat Med 2019;25:1519—25.
70.
Nair R, Mohan DD, Frank S, Setlur S, Govindaraju V, Ramanathan M. Generative adversarial networks for modelling clinical biomarker profiles with race/ethnicity. Br J Clin Pharmacol 2023;89:1588—600.
71.
Wu SH, Tong WJ, Li MD, Hu HT, Lu XZ, Huang ZR, et al. Collaborative enhancement of consistency and accuracy in US diagnosis of thyroid nodules using large language models. Radiology 2024;310:e232255.
72.
Lu Y, Liu D, Liang Z, Liu R, Chen P, Liu Y, et al. A pretrained transformer model for decoding individual glucose dynamics from continuous glucose monitoring data. Natl Sci Rev 2025;12:nwaf039.
73.
Scheffer M, Bascompte J, Brock WA, Brovkin V, Carpenter SR, Dakos V, et al. Early-warning signals for critical transitions. Nature 2009;461:53—9.
74.
Scheffer M, Carpenter SR, Lenton TM, Bascompte J, Brock W, Dakos V, et al. Anticipating critical transitions. Science 2012;338:344—8.
75.
Chen L, Liu R, Liu ZP, Li M, Aihara K. Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers. Sci Rep 2012;2:342.
76.
Tang S, Yuan K, Chen L. Molecular biomarkers, network biomarkers, and dynamic network biomarkers for diagnosis and prediction of rare diseases. Fundam Res 2022;2:894—902.
77.
Zhong J, Tang H, Huang Z, Chai H, Ling F, Chen P, et al. Uncovering the pre-deterioration state during disease progression based on Sample-Specific Causality Network Entropy (SCNE). Research 2024;7:0368.
78.
Zhong J, Han C, Wang Y, Chen P, Liu R. Identifying the critical state of complex biological systems by the directed-network rank score method. Bioinformatics 2022;38:5398—405.
79.
Yang B, Li M, Tang W, Liu W, Zhang S, Chen L, et al. Dynamic network biomarker indicates pulmonary metastasis at the tipping point of hepatocellular carcinoma. Nat Commun 2018;9:678.
80.
Fang Z, Han X, Chen Y, Tong X, Xue Y, Yao S, et al. Oxidative stress-triggered Wnt signaling perturbation characterizes the tipping point of lung adeno-to-squamous transdifferentiation. Signal Transduct Target Ther 2023;8:16.
81.
Chen P, Chen E, Chen L, Zhou XJ, Liu R. Detecting early-warning signals of influenza outbreak based on dynamic network marker. J Cell Mol Med 2019;23:395—404.
82.
Koizumi K, Oku M, Hayashi S, Inujima A, Shibahara N, Chen L, et al. Identifying pre-disease signals before metabolic syndrome in mice by dynamical network biomarkers. Sci Rep 2019;9:8767.
83.
Li L, Xu Y, Yan L, Li X, Li F, Liu Z, et al. Dynamic network biomarker factors orchestrate cell-fate determination at tipping points during hESC differentiation. Innov 2023;4:100364.
84.
Zhong J, Han C, Zhang X, Chen P, Liu R. scGET: predicting cell fate transition during early embryonic development by Single-cell Graph Entropy. Genomics Proteomics Bioinformatics 2021;19:461—74.
85.
Chen P, Zhong J, Yang K, Zhang X, Chen Y, Liu R. TPD: a web tool for tipping-point detection based on dynamic network biomarker. Brief Bioinform 2022;23:bbac399.
86.
Liu R, Chen P, Chen L. Corrigendum to: single-sample landscape entropy reveals the imminent phase transition during disease progression. Bioinformatics 2020;36:2644.
87.
Li S, Wang BY, Cao L, Xiao LH, Chen P, Zhang B, et al. Research and development practice of traditional Chinese medicine based on network target theory and technology. Zhongguo Zhong Yao Za Zhi 2023;48:5965—76.
88.
Zhang P, Zhang D, Zhou W, Wang L, Wang B, Zhang T, et al. Network pharmacology: towards the artificial intelligence-based precision traditional Chinese medicine. Brief Bioinform 2023;25:bbad518.
89.
Bao Z, Zheng Y, Li X, Huo Y, Zhao G, Zhang F, et al. A simple pre-disease state prediction method based on variations of gene vector features. Comput Biol Med 2022;148:105890.
90.
Shen X, Sasahara H, Imura Ji, Oku M, Aihara K. Data-driven re-stabilization of gene regulatory network towards early medical treatment. IFAC Pap Online 2023;56:6200—5.
91.
Chen P, Liu R, Li Y, Chen L. Detecting critical state before phase transition of complex biological systems by hidden Markov model. Bioinformatic 2016;32:2143—50.
Year 2025 volume 15 Issue 5
PDF
10
7
Cite this Article
BibTeX
Article Info
doi: 10.1016/j.apsb.2025.03.009
  • Receive Date:2024-11-26
  • Online Date:2026-09-17
Article Data
Affiliations
History
  • Received:2024-11-26
  • Revised:2025-02-27
  • Accepted:2025-03-05
Affiliations
    aInstitute of Traditional Chinese Medicine and Natural Products, College of Pharmacy/Guangdong Engineering Research Center of Traditional Chinese Medicine & Disease Susceptibility/Guangdong Engineering Research Center of Traditional Chinese Medicine & Health Products/International Cooperative Laboratory of TCM Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE)/Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research/State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou 510632, China
    bState Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau 999078, China
    cFaculty of Data Science, City University of Macau, Macau 999078, China
    dCollege of Information Science and Technology, Jinan University, Guangzhou 510632, China
    eMedical Big Data Center, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510632, China
    fThe Data Center, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430016, China

Corresponding:

* Corresponding authors.
References
Share
https://castjournals.cast.org.cn/joweb/apsb/EN/10.1016/j.apsb.2025.03.009
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT